Substances
Is Lyrica (Pregabalin) a Controlled Substance? A Usage & Scheduling Guide
Table of Contents
Key Points
- Lyrica is a Schedule V controlled substance due to its potential for misuse and dependency.
- Lyrica is FDA‑approved for neuropathic pain, fibromyalgia, and partial‑onset seizures, with dosing tailored to response.
- Strict prescription, dispensing, and monitoring guidelines help ensure the safe and legal use of medications, minimizing the risks of abuse.
Quick Answer: Yes. Lyrica (pregabalin) is a federally controlled Schedule V substance in the United States. The DEA placed it in Schedule V in 2005 because it has a recognized but lower potential for abuse and dependence than drugs in Schedules I–IV. It is not an opioid or a narcotic. A valid prescription from a DEA-registered provider is required, and both brand-name Lyrica and generic pregabalin are covered.
A controlled substance is any compound regulated at the federal level by the government due to its potential for dependency, abuse, and addiction. Controlled substances are categorized into “schedules” by the DEA, from Schedule I through Schedule V. The category or schedule each substance is put into is based on its medical utility, safety & toxicity profiles, abuse potential, and more.[1] Schedule V drugs are considered the “lowest” category in terms of restriction, and Schedule I is the most restrictive category.
What is Lyrica’s (Pregabalin) Drug Schedule Classification?
Pregabalin is the generic name for Lyrica, and it’s classified as a Schedule V controlled substance.[2] Schedule V drugs have a lower potential for abuse compared to other schedules; however, the potential is still significant enough to justify caution on the federal level. With Schedule V, the substances typically require controlled distribution because misuse can still cause both physical and psychological dependence.
Why is Lyrica (Pregabalin) a controlled substance?
Lyrica is classified as a Schedule V substance due to the potential for dependency, particularly with long-term use or among those who misuse the substance, knowingly or not. Even though it’s considered far safer than many other narcotics, healthcare providers are still bound by federal law to follow regulatory prescription guidelines.
These guidelines ensure that prescriptions of Lyrica are monitored. Prescribers need to follow specific dispensing regulations that dictate the dosage and refill frequency to minimize the risk of dependence or abuse. Pharmacies also need to keep detailed records for federally scheduled substances, typically tracking prescriptions for compliance and to prevent diversion or misuse.
Why is Lyrica a Controlled Substance and Neurontin is not?
Lyrica is a controlled substance because it is absorbed more predictably and produces faster, more consistent effects in the brain — including euphoria and relaxation — which clinical studies and real-world data linked to measurable abuse potential. Neurontin absorbs more slowly and inconsistently and is not federally scheduled, but growing misuse has led several states and regulators to actively monitor and restrict it through prescription drug enforcement programs.
Lyrica vs. Other Commonly Prescribed Medications: Drug Schedules
| Medication | Drug Class | Federal Schedule | Notes |
| Lyrica (pregabalin) | Anticonvulsant / nerve-pain medication | Schedule V | Lowest-restriction controlled category |
| Neurontin (gabapentin) | Anticonvulsant / nerve-pain medication | Not federally controlled | Scheduled or monitored in some states |
| Xanax (alprazolam) | Benzodiazepine | Schedule IV | Higher dependence risk than Lyrica |
| Ultram (tramadol) | Opioid | Schedule IV | Acts on opioid receptors |
| Oxycodone | Opioid | Schedule II | High abuse potential |
What Does Lyrica’s Federal Scheduling Mean for Patients
For patients, it’s critical to know that long-term Lyrica use can reinforce dependency. For many, just knowing that it’s on the list of federally controlled narcotics is enough to stress how important it is to stick to the prescribed dosage amount and frequency.
Patients should avoid sharing Lyrica with anyone else, even others with a prescription, since dosages can vary from person to person. For anyone without a valid prescription, unauthorized possession, use, or distribution of Lyrica can result in substantial penalties, which may include federal charges, fines, and imprisonment.
Is Lyrica a Controlled Substance in Every State?
Yes. Because pregabalin is federally scheduled, it is treated as a controlled substance in every U.S. state. States can add stricter rules on top of the federal baseline, so requirements for prescriptions, quantity limits, and monitoring may differ depending on where you live.
Most states require pharmacies to report controlled-substance prescriptions to the state Prescription Drug Monitoring Program (PDMP), a database that helps providers spot overlapping prescriptions and patterns of misuse. Some states have also gone further with gabapentin (Neurontin), which is not federally scheduled. Kentucky, Tennessee, Virginia, and Michigan, for example, have classified it as a controlled substance, and many other states require gabapentin prescriptions to be reported to the PDMP.
For the exact rules in your state, check with your prescriber, your pharmacist, or your state board of pharmacy.
Medical Uses of Lyrica (Pregabalin)
Lyrica is an approved treatment for several conditions related to neurology and pain, making it a versatile option in clinical practice. The three biggest use cases are neuropathic pain, fibromyalgia, and seizure management. Lyrica binds to voltage‑gated calcium channels in nerve terminals, similar to how gabapentin works, reducing the release of excitatory neurotransmitters that signal nerve pain. This is also known as GABA-ergic signaling. It’s most commonly prescribed for peripheral neuropathy and postherpetic neuralgia.[3]
Both Lyrica and gabapentin are GABA analogs, which gives them a wide range of “off-label” use as treatments for chronic pain. However, Lyrica’s Schedule V status is a good indication of its slightly higher potential for addiction compared to gabapentin.
Fibromyalgia is another primary condition treated by Lyrica, and is characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues. Lyrica is one of the few medications FDA‑approved to manage fibromyalgia symptoms. In clinical trials, patients experienced significant reductions in pain scores and improvement in sleep quality. [4]
Originally approved as an anticonvulsant, Lyrica also serves as an adjunctive therapy for partial-onset seizures in adults. Through a mechanism that modulates calcium influx at nerve terminals during nerve pain flare-ups, it helps decrease neuronal hyperexcitability, which contributes to seizure activity. When used with other antiepileptic drugs, Lyrica can reduce seizure frequency by up to 50% in some patients. [5]
Is Lyrica (Pregabalin) an Opioid?
No, Lyrica (pregabalin) is not an opioid, it’s an anticonvulsant (antiepileptic) drug that works differently by calming nerve activity. It does not act on opioid receptors like morphine or oxycodone. However, it can be misused for euphoria and carries addiction risks. This is what has led to its status as a controlled substance and warnings about combining it with actual opioids due to dangerous CNS depression.
Is Lyrica (Pregabalin) a Narcotic?
No, Lyrica (pregabalin) is not a narcotic; it is an anticonvulsant and nerve-pain medication that works by calming overactive nerve signals in the brain. However, it is classified as a Schedule V controlled substance in the U.S. because it can produce relaxing or euphoric effects and carries a recognized, though lower, risk of misuse and dependence.
Precautions & Considerations for Lyrica Users
While Lyrica provides measurable relief for neuropathic and seizure disorders, patients and providers still need to remain cognizant of safety cautions and proper use.
Common Lyrica Side Effects & Risks
While it’s generally well-tolerated, there are some potential side effects and risks to be aware of if you’re using Lyrica, whether prescribed or not. The most commonly reported side effects include dizziness, somnolence, unintended weight gain, and peripheral edema. In most cases, these side effects are dose-dependent and are more noticeable during the initial titration period.
During this period, and until you’re familiar with how Lyrica impacts your alertness, you should avoid driving or operating any heavy machinery. It’s also important to regularly monitor your weight and any swelling you notice in your extremities to detect early signs of fluid retention.
Risks of Misuse and Possible Dependency
As a federally scheduled controlled substance, Lyrica has a mild to moderate potential for misuse and abuse. Those with an established history of substance abuse or a diagnosis of substance use disorder will face a significantly higher risk of dependency.
Prescribers can help mitigate misuse by:
- Limiting prescription quantities to prevent excessive or unneeded refills.
- Conducting occasional assessments of patient prescription data for signs of drug-seeking behavior.
- Helping patients educate themselves on safe storage of active prescriptions and proper disposal of unused doses.
Additionally, as a mild CNS depressant, Lyrica can interact adversely with other depressants, particularly powerful ones like opioids, benzodiazepines, and alcohol. Combining Lyrica with other depressants can lead to dangerous sedation and a greatly elevated risk of respiratory depression. Lyrica is also contraindicated in patients who have a known hypersensitivity to pregabalin or its components.
Signs of Lyrica Misuse or Dependence
Lyrica can cause a feeling of calm or euphoria at higher doses, which is why some people misuse it. Warning signs include:
- Taking more than prescribed or taking doses more often than directed
- Running out of medication early or asking for early refills
- Getting Lyrica from more than one prescriber or from someone else
- Taking it to feel relaxed or “high” rather than for pain or seizures
- Combining it with alcohol, opioids, or benzodiazepines
- Feeling unable to cut down, or feeling anxious or unwell between doses
Lyrica Withdrawal Symptoms
Stopping Lyrica abruptly can cause withdrawal-type symptoms, even in people who take it exactly as prescribed. Common symptoms include:
- Insomnia
- Headache
- Nausea and diarrhea
- Anxiety or irritability
- Sweating
- Flu-like symptoms
People who take Lyrica for seizures are also at risk of seizures if it is stopped suddenly. The FDA-approved labeling recommends tapering gradually over at least one week, but the right schedule should always be set by your prescriber.
Why Mixing Lyrica With Opioids or Alcohol Is Dangerous
Lyrica slows the central nervous system. Combined with opioids, benzodiazepines, or alcohol, it can cause extreme drowsiness, slowed or stopped breathing, and overdose. The FDA has also warned that gabapentinoids like pregabalin can cause serious breathing problems in people with respiratory conditions, older adults, and those taking other CNS depressants. Seek emergency care right away for slow or shallow breathing, extreme sleepiness, or unresponsiveness.
How Lyrica Differs from Opioid Pain Relievers
Opioid medications like codeine typically have a much higher risk for dependence and respiratory depression. But Lyrica targets nerve pain with a more direct mechanism of action, without the need for acting on opioid receptors. This makes it a safer option for long-term management of neuropathic conditions. Codeine remains useful for acute pain flares, but its classification as an opioid demands stricter monitoring, making Lyrica safer and more versatile.
Tips for Safe & Lawful Use
- Ensure your prescription is up to date and that it was issued lawfully by your provider.
- Follow the dose and frequency instructions exactly to avoid misuse. Do not change your dose or the frequency of your medication unless your healthcare provider instructs you to do so.
- Keep your Lyrica stored in a secure location away from other individuals and pets.
- If you need to dispose of unused prescriptions, find a local municipal drug take-back program, or follow your provider’s directions for the remaining tablets.
Legal and Prescription Guidelines
All substances in Schedule V have controlled prescription and distribution, and Lyrica is no exception. Both federal and state regulations aim to prevent misuse while ensuring that patients who require Lyrica as a treatment can still access it.
Lyrica Prescription Requirements and Limits
Only healthcare providers registered with the DEA are permitted to prescribe Lyrica, and many states also require a written or secure digital prescription e-signed by the prescriber. The refill limits on Schedule V substances typically limit patients to five refills within six months of the original prescription date, beyond which a new prescription is needed.
Lyrica Prescription Record‑Keeping and Monitoring
Pharmacists and pharmacy technicians are required to log every dispensation of Lyrica in their records. This records patient information, prescription dates, dispensed dosages, and the quantities dispensed. Providers and pharmacists are also required to consult the state Prescription Drug Monitoring Program before prescribing or dispensing Lyrica to identify any potential patterns of misuse or drug-seeking behavior like doctor shopping. Overall, these safeguards help create a framework where patients are kept as safe as possible, and providers are empowered to protect themselves from issuing dangerous or harmful prescriptions.
Find The Help You Need
Lyrica is a legitimate and effective medication for many people, but it carries a real risk of dependence, especially for anyone with a history of substance use. If you or a loved one is taking more than prescribed, using Lyrica without a prescription, or mixing it with opioids, benzodiazepines, or alcohol, speak with a healthcare professional soon. Do not stop Lyrica suddenly on your own.
IKON Recovery offers medically supervised detox, intensive outpatient treatment, and dual diagnosis care for people struggling with prescription drug misuse. You can learn more about prescription drug addiction treatment, check your insurance options, or call (844) 394-4566 to speak with an admissions specialist.
